These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 345253)

  • 1. Plasma concentration/time curve of erythromycin after a 12-hour intravenous infusion of erythromycin lactobionate in man.
    Parsons RL; David J; Paddock GM; Stamp ST
    Postgrad Med J; 1978 Feb; 54(628):68-71. PubMed ID: 345253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of intravenous erythromycin lactobionate.
    Parsons RL; David JA; Raymond K; Stamp SM
    J Int Med Res; 1980; 8 Suppl 2():15-23. PubMed ID: 6968696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythromycin levels in serum during treatment with erythromycin stearate and base.
    Saarni H; Kanto J; Allonen H
    Ann Clin Res; 1979 Oct; 11(5):196-8. PubMed ID: 397800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous administration of erythromycin: serum, sputum and urine levels.
    Neaverson MA
    Curr Med Res Opin; 1976; 4(5):359-64. PubMed ID: 1009781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythromycin infusions for treatment of infections in the ear, nose and throat region.
    Blenk H; Blenk B; Jahneke G; Simm K; von Lucke B; LaFranier D
    J Int Med Res; 1980; 8 Suppl 2():41-6. PubMed ID: 7429005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The pharmacokinetics of 1,000 mg erythromycin lactobionate i. v. in patients with respiratory tract infections (author's transl)].
    Sietzen W
    Infection; 1982; 10 Suppl 2():S99-101. PubMed ID: 7107025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Side-effects due to the intravenous infusion of erythromycin lactobionate.
    Putzi R; Blaser J; Lüthy R; Wehrli R; Siegenthaler W
    Infection; 1983; 11(3):161-3. PubMed ID: 6885176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythromycin (2 X 1 g) as a Regimen for community-acquired pneumonia.
    Simmen HP; Lüthy R
    Infection; 1982; 10 Suppl 2():S84-5. PubMed ID: 7107023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacokinetics and therapeutic efficacy of erythromycin lactobionate in childhood].
    Scotti L; Felicetta I; Boccazzi A; Borzani M
    Minerva Pediatr; 1987 Dec; 39(23-24):1167-70. PubMed ID: 3451072
    [No Abstract]   [Full Text] [Related]  

  • 10. Study of serum levels, venous irritation and gastrointestinal side-effects with intravenous erythromycin lactobionate in patients with bronchopulmonary infection.
    Marlin GE; Thompson PJ; Jenkins CR; Burgess KR; LaFranier DA
    Hum Toxicol; 1983 Oct; 2(4):593-605. PubMed ID: 6642516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastrointestinal side effects after intravenous erythromycin lactobionate.
    Downey KM; Chaput de Saintonge DM
    Br J Clin Pharmacol; 1986 Mar; 21(3):295-9. PubMed ID: 3964530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous erythromycin in acute chest infections in critically ill patients.
    Cade JF; Pain MC
    Anaesth Intensive Care; 1979 May; 7(2):143-7. PubMed ID: 507348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biliary excretion of erythromycin after parenteral administration.
    Chelvan P; Hamilton-Miller JM; Brumfitt W
    Br J Clin Pharmacol; 1979 Sep; 8(3):233-5. PubMed ID: 497089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacodynamics of erythromycin lactobionate during tonsillectomy in children].
    Leuthardt R; Trümpi B; Morger R
    Schweiz Med Wochenschr; 1989 Oct; 119(40):1372-4. PubMed ID: 2799345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of intravenous erythromycin lactobionate in respiratory infections.
    Di Sciacca A; Durante F; Cucchiara G; Ingrassia A; Mira G; Mannone F; Di Piazza RM; Frontini A; Barbagallo Sangiorgi G
    J Int Med Res; 1987; 15(4):245-50. PubMed ID: 3653502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythromycin pharmacokinetics in man.
    Houin G; Tillement JP; Lhoste F; Rapin M; Soussy CJ; Duval J
    J Int Med Res; 1980; 8 Suppl 2():9-14. PubMed ID: 7429008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral administration of erythromycin stearate: effect of dosage form on plasma levels.
    Triggs EJ; Ashley JJ
    Med J Aust; 1978 Jul; 2(3):121-3. PubMed ID: 713930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of microbiologic and high-performance liquid chromatography assays to determine plasma concentrations, pharmacokinetics, and bioavailability of erythromycin base in plasma of foals after intravenous or intragastric administration.
    Lakritz J; Wilson WD; Mihalyi JE
    Am J Vet Res; 1999 Apr; 60(4):414-9. PubMed ID: 10211682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double-blind comparative trial of trimethoprim/sulfamethopyrazine once daily vs erythromycin 4 X daily in patients with ENT infections.
    Federspil P; Koch J
    Int J Clin Pharmacol Ther Toxicol; 1983 Oct; 21(10):535-9. PubMed ID: 6358058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Tolerance and effectiveness of oral erythromycin ethyl succinate, intravenous Lactobionate and erythromycin base in infants and small children].
    Krepler P; Steinwenter A
    Arch Kinderheilkd; 1970 Jan; 180(2):129-50. PubMed ID: 5443953
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.